Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.395
-0.020 (-4.73%)
Nov 22, 2024, 4:00 PM EST - Market closed
Xtant Medical Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 113.86 | 91.3 | 57.97 | 55.15 | 53.19 | 64.52 | Upgrade
|
| Other Revenue | - | - | - | 0.12 | 0.15 | 0.17 | Upgrade
|
| Revenue | 113.86 | 91.3 | 57.97 | 55.26 | 53.34 | 64.68 | Upgrade
|
| Revenue Growth (YoY) | 45.11% | 57.50% | 4.90% | 3.61% | -17.54% | -10.42% | Upgrade
|
| Cost of Revenue | 44.53 | 35.84 | 25.83 | 22.77 | 18.95 | 22.17 | Upgrade
|
| Gross Profit | 69.33 | 55.47 | 32.14 | 32.49 | 34.39 | 42.52 | Upgrade
|
| Selling, General & Admin | 80.97 | 64.29 | 37.98 | 34.87 | 34.49 | 43.84 | Upgrade
|
| Research & Development | 2.36 | 1.34 | 0.92 | 0.87 | 0.66 | 0.93 | Upgrade
|
| Operating Expenses | 83.33 | 65.63 | 38.89 | 35.74 | 35.14 | 44.77 | Upgrade
|
| Operating Income | -14 | -10.16 | -6.76 | -3.25 | -0.75 | -2.25 | Upgrade
|
| Interest Expense | -3.84 | -2.94 | -1.69 | -1 | -5.98 | -5.77 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.15 | 0.03 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.37 | 0.27 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.05 | - | - | - | -0.1 | Upgrade
|
| EBT Excluding Unusual Items | -17.51 | -12.73 | -8.42 | -4.25 | -6.73 | -8.12 | Upgrade
|
| Legal Settlements | - | - | - | -0.6 | - | - | Upgrade
|
| Other Unusual Items | 0.67 | 11.69 | - | - | - | - | Upgrade
|
| Pretax Income | -16.84 | -1.04 | -8.42 | -4.85 | -6.73 | -8.12 | Upgrade
|
| Income Tax Expense | 0.74 | -1.7 | 0.07 | - | 0.3 | 0.1 | Upgrade
|
| Net Income | -17.59 | 0.66 | -8.49 | -4.85 | -7.02 | -8.22 | Upgrade
|
| Net Income to Common | -17.59 | 0.66 | -8.49 | -4.85 | -7.02 | -8.22 | Upgrade
|
| Shares Outstanding (Basic) | 131 | 119 | 94 | 85 | 28 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 131 | 127 | 94 | 85 | 28 | 13 | Upgrade
|
| Shares Change (YoY) | 9.53% | 34.76% | 10.10% | 199.85% | 116.50% | 12.12% | Upgrade
|
| EPS (Basic) | -0.13 | 0.01 | -0.09 | -0.06 | -0.25 | -0.62 | Upgrade
|
| EPS (Diluted) | -0.13 | 0.01 | -0.09 | -0.06 | -0.25 | -0.63 | Upgrade
|
| Free Cash Flow | -17.28 | -10.97 | -7.11 | -1.68 | -2.28 | -1.29 | Upgrade
|
| Free Cash Flow Per Share | -0.13 | -0.09 | -0.08 | -0.02 | -0.08 | -0.10 | Upgrade
|
| Gross Margin | 60.89% | 60.75% | 55.44% | 58.79% | 64.48% | 65.73% | Upgrade
|
| Operating Margin | -12.29% | -11.13% | -11.65% | -5.89% | -1.41% | -3.48% | Upgrade
|
| Profit Margin | -15.45% | 0.72% | -14.64% | -8.77% | -13.17% | -12.71% | Upgrade
|
| Free Cash Flow Margin | -15.18% | -12.02% | -12.26% | -3.03% | -4.27% | -2.00% | Upgrade
|
| EBITDA | -9.91 | -6.98 | -5.46 | -1.92 | 1.33 | 0.89 | Upgrade
|
| EBITDA Margin | -8.70% | -7.65% | -9.42% | -3.48% | 2.49% | 1.38% | Upgrade
|
| D&A For EBITDA | 4.09 | 3.17 | 1.29 | 1.33 | 2.08 | 3.14 | Upgrade
|
| EBIT | -14 | -10.16 | -6.76 | -3.25 | -0.75 | -2.25 | Upgrade
|
| EBIT Margin | -12.29% | -11.13% | -11.65% | -5.89% | -1.41% | -3.48% | Upgrade
|
| Revenue as Reported | - | - | - | 55.26 | 53.34 | 64.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.